Age Related Macular Degeneration Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

Age Related Macular Degeneration Market is projected to reach revenue of $12.85 billion by 2028, and is estimated to grow at a CAGR of 7% during the forecast period 2022-2028.

Age-related macular degeneration is also called macular degeneration, ARMD, or AMD. AMD is a retinal disease that causes sharp blurring of central vision that is important for a variety of forward-looking activities, such as driving, using computers, watching television, sewing, and reading. In AMD, the part of the retina called the macula is affected where you can see fine details. AMD is a chronic eye disease that does not cause pain. It is mainly observed in patients over 50 years of age. AMD is the leading cause of vision loss among the elderly in the United States. The growing geriatric population in the United States and other countries is expected to significantly increase the prevalence of AMD over the next few years. The disease is more pronounced in developed countries and accounts for 8.7% of global blindness.

Market Segments

By Product

• Wet AMD
• Dry AMD

By Drug

• Lucentis
• Eylea
• Avastin

Key Players

• Hoffmann-La Roche AG
• Bausch & Lomb Incorporate
• Novartis AG, Pfizer Inc
• ALLERGAN
• Acucela Inc.
• Santen Pharmaceuticals Co.
• Ophthotech Corporation
• Alimera Sciences Inc.
• GlaxoSmithKline PLC

Scope of the Report

The research study analyzes the global Age Related Macular Degeneration industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Age Related Macular Degeneration Market Report

1. What was the Age Related Macular Degeneration Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Age Related Macular Degeneration Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Age Related Macular Degeneration Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.